PER 0.00% 8.0¢ percheron therapeutics limited

should buy now, page-60

  1. 2,405 Posts.
    Cancer (Breast)
    Breast cancer is the third most prevalent cancer in the world and it has been reported that rates of
    the disease increased two fold in premenopausal women with higher levels of serum IGF-I. In
    addition, elevated GHr expression is observed in breast cancer tissues.

    Clinically significant disease remission was achieved in breast cancer patients who had part of their
    pituitary gland surgically removed, which in turn reduced their GH and associated serum IGF-I levels.
    thereby supporting the potential of ATL1103 as a treatment for breast cancer.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.3¢ 8.4¢ 8.0¢ $99.06K 1.226M

Buyers (Bids)

No. Vol. Price($)
1 3500 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 40625 1
View Market Depth
Last trade - 16.10pm 19/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.